Cargando…
Interferon: A Sharp Sword to Overcome HCV or HBV-Related Liver Diseases?
Autores principales: | Jia, Wei-Dong, Zhang, Chuan-Hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269091/ https://www.ncbi.nlm.nih.gov/pubmed/22308146 |
Ejemplares similares
-
HBV and HCV Coinfection Associated with Warm-Type Autoimmune Hemolytic Anemia: A Case Report
por: Zhang, Quan-le, et al.
Publicado: (2014) -
Are HIV, HBV and HCV Voluntary Counseling and Testing Programs Needed in Balkans?
por: Sultana, Camelia, et al.
Publicado: (2018) -
SARS-CoV-2 in patients on antiviral HBV and HCV therapy in Spain
por: Lens, Sabela, et al.
Publicado: (2020) -
Prevalence of HBV, HCV and HIV in Inpatients of a Mental Health Hospital in Turkey, 2011–2013
por: KARABULUT, Nuran
Publicado: (2015) -
Circulating Interferon-λ3, Responsiveness to HBV Vaccination, and HBV/HCV Infections in Haemodialysis Patients
por: Grzegorzewska, Alicja E., et al.
Publicado: (2017)